financetom
Business
financetom
/
Business
/
Eastman Chemical Q1 Adjusted Earnings, Revenue Fall; 2024 EPS Outlook Maintained
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Eastman Chemical Q1 Adjusted Earnings, Revenue Fall; 2024 EPS Outlook Maintained
Apr 25, 2024 3:05 PM

05:40 PM EDT, 04/25/2024 (MT Newswires) -- Eastman Chemical ( EMN ) reported Q1 adjusted earnings late Thursday of $1.61 per diluted share, down from $1.63 per share a year earlier.

Analysts polled by Capital IQ expected $1.43.

Revenue for the quarter ended March 31 fell to $2.31 billion from $2.41 billion a year earlier. Analysts surveyed by Capital IQ expected $2.29 billion.

For 2024, the company said it continues to expect EPS of $7.25 to $8. The consensus is for $7.67.

Price: 96.40, Change: +0.27, Percent Change: +0.28

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BMW CEO sees 'perfect set-up' in U.S. market
BMW CEO sees 'perfect set-up' in U.S. market
Nov 6, 2024
FRANKFURT, Nov 6 (Reuters) - BMW is well-positioned for any possible import tariffs in the United States, its CEO told analysts on Wednesday, saying two thirds of its local sales were produced in its Spartanburg plant in South Carolina. Oliver Zipse said that BMW's perfect set-up in the U.S. market provided a natural cover-up for potential tariffs, which have been...
Novo Nordisk: aware of 10 deaths from compounded weight-loss drug copies
Novo Nordisk: aware of 10 deaths from compounded weight-loss drug copies
Nov 6, 2024
LONDON, Nov 6 (Reuters) - Novo Nordisk on Wednesday said it is aware of 100 hospitalizations and 10 deaths resulting from people taking compounded copies of its popular weight-loss and diabetes drugs. ...
Novo Nordisk says it is aware of 10 deaths from compounded weight-loss drug copies
Novo Nordisk says it is aware of 10 deaths from compounded weight-loss drug copies
Nov 6, 2024
LONDON, Nov 6 (Reuters) - Novo Nordisk is aware of 100 hospitalizations and 10 deaths resulting from people taking compounded copies of its popular weight-loss and diabetes drugs, the drugmaker's finance chief said on Wednesday. Chief Financial Officer Karsten Munk Knudsen told a media briefing after the company released third-quarter results that the company had been looking at a number...
Puma CEO sees better holiday trading after Q3 sales miss expectations
Puma CEO sees better holiday trading after Q3 sales miss expectations
Nov 6, 2024
* Puma Q3 sales up 5% to 2.31 bln euros * EMEA sales grow just 0.8% * Weaker foreign currencies hurt sales in euro terms * Puma CEO says demand for 'Speedcat' shoe is growing (Adds CEO quotes in paragraphs 2, 3, 9 and 10, updates share price) By Linda Pasquini and Helen Reid Nov 6 (Reuters) - German sportswear...
Copyright 2023-2026 - www.financetom.com All Rights Reserved